Notice Type
Departmental
Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Paroxetine hydrochloride 24.9 mg equivalent to 20 mg paroxetine Tablet Les Laboratories Beecham, Mayenne, France and SmithKline Beecham Pharmaceuticals, Magpie Wood, Manor Royal, Crawley, Sussex, England Aropax 20 Paroxetine hydrochloride 24.9 mg equivalent to 20 mg paroxetine Tablet Les Laboratories Beecham, Mayenne, France and SmithKline Beecham Pharmaceuticals, Magpie Wood, Manor Royal, Crawley, Sussex, England Aropax 20 Alendronate sodium 13.05 mg, 52.21 mg equivalent to 10 mg, 40 mg alendronic acid Tablets Merck Manufacturing Division, Arecibo, Puerto Rico and Merck Sharp & Dohme Italia SpA., Pavia, Italy Fosamax Sodium fusidate 250 mg Tablet, film coated Leo Pharmaceutical Products (Lovens Kemiske Fabrik), Ballerup, Denmark Fucidin Ethinylestradiol 0.02 mg, gestodene 0.075 mg Tablet Schering AG., Berlin, Germany Melodene Nicotine 2 mg, 4 mg Chewing gum Pharmacia AB., Helsingborg, Sweden Nicorette (Citrus flavour) Mesalazine 1 g Granules, modified release Ferring A/S (Synthese A/S)., Vanlose, Denmark Pentasa Ramipril 1.25 mg, 2.5 mg, 5 mg, 10 mg Tablets Hoechst AG., Frankfurt (Main), Germany Ramace Pantoprazole sodium sesquihydrate 45.1 mg equivalent to 40 mg pantoprazole Tablet, enteric coated Byk Gulden Lomberg Chemische Fabrik GmbH., Konstanz, Germany and Oranienburger Pharmawerk GmbH., Oranienburg, Germany Somac Nisoldipine 10 mg, 20 mg, 30 mg, 40 mg Tablet, modified release Bayer AG., Leverkusen, Germany Syscor CC Valaciclovir hydrochloride 556 mg, 1112 mg equivalent to 500 mg, 1000 mg valaciclovir Tablets, film coated Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom Valaciclovir Valaciclovir hydrochloride 556 mg equivalent to 500 mg valaciclovir Tablets, film coated Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom and Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Valtrex Valaciclovir hydrochloride 1112 mg equivalent to 1000 mg valaciclovir Tablets, film coated Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom Valtrex Ondansetron hydrochloride dihydrate 2 mg/mL in 2 mL, 4mL Injection, ampoules Glaxo Wellcome Australia Limited, Boronia, Victoria, Australia Zofran Lansoprazole 15 mg, 30 mg Capsules Lederle Laboratories, Cyanamid of Great Britain Limited, Gosport, Hampshire, United Kingdom and Wyeth Medica Ireland, Little Connell, Newbridge, County Kildare, Eire Zoton Cetirizine hydrochloride 10 mg Tablet Laboratori UCB SpA., Pianezza, Italy and UCB Pharma SA., Chemin du Foriest, Braine-l'Alleud, Brussels, Belgium Zyrtec Cetirizine hydrochloride 1 mg/mL in 75 mL Solution, oral Laboratori UCB SpA., Pianezza, Italy and UCB Pharma SA., Chemin du Foriest, Braine-l'Alleud, Brussels, Belgium Zyrtec Cetirizine hydrochloride 10 mg/mL in 10 mL Solution, oral drops Laboratori UCB SpA., Pianezza, Italy and UCB Pharma SA., Chemin du Foriest, Braine-l'Alleud, Brussels, Belgium Zyrtec Dated this 19th day of September 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
Publication Date
25 Sep 1997

Notice Number

1997-go6737

Page Number

3244